PROstate cancer follow-up care in Secondary and Primary hEalth Care: PROSPEC study.
Recruiting
- Conditions
- Prostate cancer, survivorship, primary care, secondary care, follow-up, general practitioner, randomised controlled trialDutch: Prostaatcarcinoom, overlevingszorg, eerstelijnszorg, tweedelijnszorg, nazorg, huisarts, gerandomiseerd gecontroleerde trial.
- Registration Number
- NL-OMON24717
- Lead Sponsor
- Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 390
Inclusion Criteria
1.Men diagnosed with invasive prostate cancer;
2.Stage cT1a–cT3; pNx–pN1; R0-1 having completed primary treatment (prostatectomy or radiotherapy);
Exclusion Criteria
1.Primary treatment (prostatectomy, radiotherapy) not completed at least 3 months previously;
2.Patients under active surveillance;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare GP-based follow-up care of prostate cancer survivors with traditional, specialist-based follow-up care in terms of adherence to the prostate surveillance guideline represented by the rate of PSA measurements.
- Secondary Outcome Measures
Name Time Method To compare the effect of GP-based follow-up care of prostate cancer survivors with traditional, specialist-based follow-up care in terms of: <br /><br>(1) The time from a BCR to prostate cancer retreatment decision-making;<br /><br>(2) The management of treatment-related side effects (APECC survey);<br /><br>(3) Health-related quality of life and prostate cancer-related anxiety (EORTC QLQ-C30, QLQ-PR25 and MAX-PC questionnaire;<br /><br>(4) Continuity of care (NCQ survey);<br /><br>(5) Costs-effectiveness (EQ-5D-5L);<br /><br>(6) Experience with the follow-up and intervention study (interviews).